Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept. [electronic resource]
Producer: 20101015Description: 944-7 p. digitalISSN:- 1365-2141
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Azacitidine -- administration & dosage
- Disease Progression
- Etanercept
- Female
- Humans
- Immunoglobulin G -- administration & dosage
- Leukemia, Myelomonocytic, Chronic -- drug therapy
- Male
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Remission Induction
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.